{
    "clinical_study": {
        "@rank": "87259", 
        "acronym": "CLOFA", 
        "arm_group": [
            {
                "arm_group_label": "Clomifene Citrate", 
                "arm_group_type": "Experimental", 
                "description": "Clomifene Citrate 50 mg"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "No intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the effect on LH levels of the 5-day CC\n      administration during luteal phase in oocyte donors, to investigate whether the CC corrects\n      the suppressed LH levels in the luteal phase and whether it prolongs the luteal phase in the\n      agonist triggered antagonist cycles."
        }, 
        "brief_title": "Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in IVF Cycles", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Female Infertility", 
        "condition_browse": {
            "mesh_term": [
                "Infertility", 
                "Infertility, Female"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Oocyte donors\n\n          -  18-35 years old\n\n          -  BMI 18-29 Kg/m2\n\n          -  Normal basal hormonal levels\n\n          -  No contraceptive pill\n\n        Exclusion Criteria:\n\n          -  Polycystic ovarian syndrome (PCOS)\n\n          -  Previous participation in the study"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01791751", 
            "org_study_id": "CLOFA", 
            "secondary_id": "2011-002173-33"
        }, 
        "intervention": {
            "arm_group_label": "Clomifene Citrate", 
            "description": "Clomiphene citrate 100 mg daily for 5 days", 
            "intervention_name": "Clomifene Citrate", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Citric Acid", 
                "Clomiphene"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 12, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Barcelona", 
                    "country": "Spain", 
                    "zip": "08029"
                }, 
                "name": "Cl\u00ednica EUGIN"
            }
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in Agonist Triggered GnRH Antagonist in Vitro Fertilization Cycles. Phase IV, Single-centre, Open-label, Controlled Clinical Trial.", 
        "overall_official": {
            "affiliation": "Clinica EUGIN", 
            "last_name": "Marta Colodron, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Spain: Spanish Agency of Medicines", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "LH Levels (IU)", 
            "safety_issue": "No", 
            "time_frame": "Luteal phase (up to 2 weeks)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01791751"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Endometrial development (Noyes criteria)", 
            "safety_issue": "No", 
            "time_frame": "Luteal phase (1 day)"
        }, 
        "source": "Fundaci\u00f3 Privada Eugin", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fundaci\u00f3 Privada Eugin", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}